Radionetics Oncology

Last updated: April 19, 2024

CEO - Paul Grayson
CEO - Paul Grayson
Country: USA | Funding: $135M (+)

Website: https://radionetics.com

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.